HOME
Donate now
EN
25 August 2014
Cervical cancer Infections

New report shows that HPV vaccine trials can be significantly shortened

A new report from a Working Group convened by the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, and the United States National Cancer Institute (NCI) shows how the evaluation and licensing of prophylactic human papillomavirus (HPV) vaccines could be significantly accelerated.IARC Press Release 226 IARC Working Group Report 7
Publication status

Published in section: IARC News

Publication date: 25 August, 2014, 0:00

Direct link: https://www.iarc.who.int/news-events/new-report-shows-that-hpv-vaccine-trials-can-be-significantly-shortened-2/

© Copyright International Agency on Research for Cancer 2024

Other news

View all

Geographic variation of mutagenic exposures in kidney cancer genomes

Scientists from the International Agency for Research on Cancer (IARC) and partner institutions h...

02.05.2024
Read more
IARC Monographs Volume 134: Aspartame monograph now available

The monograph on aspartame, the first monograph in IARC Monographs Volume 134: Aspartame, Methyle...

29.04.2024
Read more
Launch of CanScreen5 training in francophone African countries

The International Agency for Research on Cancer (IARC) is pleased to announce the launch of the C...

29.04.2024
Read more